PneumoRecs VaxAdvisor3.3 - App Store

This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.

Version History Minor edits. 3.3 08/21/2025 Updated Home Screen. 3.2 01/15/2025 Minor update. 3.1 12/31/2024 Updated to include the vaccination recommendation for adults at 50 years and older. 3.0 12/10/2024 Now includes an announcement about new adult pneumococcal vaccination recommendations. 2.1 12/04/2024 The app now includes recommendations for PCV21 in adults. 2.0 09/11/2024 This updated version of the app ensures that all content aligns with the latest published recommendations. 1.9 10/12/2023 Updated guidance for using PCV20 in children is now included. 1.8 09/20/2023 Minor updates to clarify recommendations 1.7 03/29/2023 This update incorporates the latest changes to the adult pneumococcal vaccination schedule, including recommendations for those who previously received PCV13. 1.6 02/08/2023 This update incorporates the option of administering PCV15 to pediatric patients. 1.5 09/15/2022 This update incorporates questions about prior PCV15 or PCV20 receipt among adults. 1.4 07/19/2022 Streamlined process for entering a patient’s age, and minor text edits to questions about history of pneumococcal vaccination. 1.3 05/25/2022 Updates have been made to include a selection for previous PCV13 vaccination among patients 19–64 years of age with chronic conditions. 1.2 04/15/2022 Updated with new PCV15 and PCV20 recommendations for adults 1.1 02/08/2022 Support for Dark Mode 1.0.10 01/13/2021 Corrected Risk Factors for pediatric populations 1.0.9 09/18/2020 Corrected Risk Factor List for 6–18 year olds. 1.0.8 06/02/2020 Updated to incorporate ACIP shared clinical decision-making recommendations for PCV13 in adults 65 years and older. 1.0.7 11/22/2019 Updated Risk Factor footnote 1.0.6 05/31/2019 Updated format of the recommendations. 1.0.5 02/12/2019 Minor Bug Fix 1.0.3 12/20/2018 1.0 12/13/2018